Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population with potent suppressive and regulative properties. MDSCs’ strong immunosuppressive potential creates new possibilities to treat chronic inflammation and autoimmune diseases or induce tolerance towards transplantation. Here,...

Full description

Bibliographic Details
Main Authors: Chiel van Geffen, Constantin Heiss, Astrid Deißler, Saeed Kolahian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.933847/full
_version_ 1828258010042990592
author Chiel van Geffen
Constantin Heiss
Astrid Deißler
Saeed Kolahian
author_facet Chiel van Geffen
Constantin Heiss
Astrid Deißler
Saeed Kolahian
author_sort Chiel van Geffen
collection DOAJ
description Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population with potent suppressive and regulative properties. MDSCs’ strong immunosuppressive potential creates new possibilities to treat chronic inflammation and autoimmune diseases or induce tolerance towards transplantation. Here, we summarize and critically discuss different pharmacological approaches which modulate the generation, activation, and recruitment of MDSCs in vitro and in vivo, and their potential role in future immunosuppressive therapy.
first_indexed 2024-04-13T02:48:51Z
format Article
id doaj.art-b45ee1843f3f42a3886df209bd377b4b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T02:48:51Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b45ee1843f3f42a3886df209bd377b4b2022-12-22T03:05:54ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-08-011310.3389/fimmu.2022.933847933847Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammationChiel van GeffenConstantin HeissAstrid DeißlerSaeed KolahianMyeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population with potent suppressive and regulative properties. MDSCs’ strong immunosuppressive potential creates new possibilities to treat chronic inflammation and autoimmune diseases or induce tolerance towards transplantation. Here, we summarize and critically discuss different pharmacological approaches which modulate the generation, activation, and recruitment of MDSCs in vitro and in vivo, and their potential role in future immunosuppressive therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2022.933847/fullMDSCpharmacotherapyimmune suppressionimmunomodulationinflammation
spellingShingle Chiel van Geffen
Constantin Heiss
Astrid Deißler
Saeed Kolahian
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
Frontiers in Immunology
MDSC
pharmacotherapy
immune suppression
immunomodulation
inflammation
title Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
title_full Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
title_fullStr Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
title_full_unstemmed Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
title_short Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
title_sort pharmacological modulation of myeloid derived suppressor cells to dampen inflammation
topic MDSC
pharmacotherapy
immune suppression
immunomodulation
inflammation
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.933847/full
work_keys_str_mv AT chielvangeffen pharmacologicalmodulationofmyeloidderivedsuppressorcellstodampeninflammation
AT constantinheiss pharmacologicalmodulationofmyeloidderivedsuppressorcellstodampeninflammation
AT astriddeißler pharmacologicalmodulationofmyeloidderivedsuppressorcellstodampeninflammation
AT saeedkolahian pharmacologicalmodulationofmyeloidderivedsuppressorcellstodampeninflammation